Prof Stephanie Schorge
Professor of Translational Neuroscience
UCL School of Pharmacy
- Joined UCL
- 1st Jan 2004
Stephanie Schorge has a long standing interest in how mutations in ion channels can cause neurological disease, and conversely how manipulating ion channels can be used to treat disease. Recently her work has focused on a developing a portfolio of gene therapy approaches to treat severe drug-refractory epilepsy, and along with several close collaborators this approach is now funded through a first in human trial due to begin recruiting patients at the end of 2019.
Teaching includes contributions to the MPharm degree at the School of Pharmacy, as well as lecturing about ion channels and biophysics at the Institute of Neurology and in Neuroscience, Pharmacology and Physiology. Stephanie holds a Senior Fellowship of the Higher Education Academy. Additional teaching includes regular contributions to the Plymouth Microelectrode Workshop.
- Other Postgraduate qualification (including professional), ATQ04 - Recognised by the HEA as a Senior Fellow |
- Brown University
- Doctorate, Doctor of Philosophy | 1999
- Yale University
- First Degree, Bachelor of Science | 1994
Stephanie has been at UCL since 1999, where she joined the Pharmacology Department as a postdoctoral researcher in single channel biophysics with Professor David Colquhoun, after which she moved to work with Professor Dimitri Kullmann at UCL Institute of Neurology. She obtained her first Fellowship from the Worshipful company of Pewterers in 2005, and her second fellowship from the Royal Society in 2010. In 2018 she moved the the UCL School of Pharmacy to become Professor in Translational Neuroscience with the aim of streamlining the translation of gene therapy research into clinical applications.